Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia.
OBJECTIVE
Aceruloplasminemia is a novel hereditary iron overload disease caused by a mutation in the ceruloplasmin gene and characterized by a complete deficiency of serum ceruloplasmin and iron accumulation in the liver and brain.


METHODS
We herein studied a novel clinical type of aceruloplasminemia in which a low amount of ceruloplasmin was detected in the serum of a patient. The patient presented with an asymptomatic hepatic iron overload, retinal degeneration, and diabetes mellitus. Magnetic resonance imaging of the liver and basal ganglia showed T2-hypointensity signals associated with parenchymal iron accumulation because of an absence of the ferroxidase activity in ceruloplasmin.


RESULTS
A gene analysis showed a novel G969S mutation in the ceruloplasmin gene. A biochemical analysis of the patients' serum and a biogenesis study of G969S mutant ceruloplasmin using mammalian cell culture system resulted in the synthesis and secretion of only apoceruloplasmin without any ferroxidase activity.


CONCLUSIONS
This novel clinical type of aceruloplasminemia should therefore be considered in the differential diagnosis of unexplained hemochromatosis, which is associated with a decrease in the serum ceruloplasmin level.
Kono
Satoshi
S
The First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Suzuki
Hitoshi
H
Takahashi
Kazuo
K
Takahashi
Yoshitomo
Y
Shirakawa
Kentaro
K
Murakawa
Yohko
Y
Yamaguchi
Shuhei
S
Miyajima
Hiroaki
H
D000368:Aged; D002478:Cells, Cultured; D002570:Ceruloplasmin / Q000172:deficiency* / Q000235:genetics; D004247:DNA / Q000235:genetics; D005260:Female; D006801:Humans; D019190:Iron Overload / Q000175:diagnosis / Q000378:metabolism*; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D020125:Mutation, Missense; D016133:Polymerase Chain Reaction
D004247:DNA; D002570:Ceruloplasmin